Mariam Oweda, Joseph N. Tanyous, M. Hamed, M. El-Hadidi
{"title":"可能用于治疗病毒引发的2型糖尿病的益生菌","authors":"Mariam Oweda, Joseph N. Tanyous, M. Hamed, M. El-Hadidi","doi":"10.1109/NILES53778.2021.9600499","DOIUrl":null,"url":null,"abstract":"The scientific literature is full of studies that provide evidence highlighting the role of microbiome in type 2 diabetes (T2D) development and progression, still, discrepancies are evident when studying the link between certain taxonomic groupings and T2D, thus, eliminating the discrepancy between such studies is crucial to build on a robust systematic approach to identify the possible linkage between such taxonomic groups and diabetes development and progression, hence developing a potential treatment. Here we aimed to use a publicly available data set of gut and nares microbiome of prediabetic individuals subjected to viral infections and controls of prediabetic healthy individuals. Analysis was done for taxa differential abundance followed by Taxon set enrichment analysis (TSEA), then, Correlations between each of the differentially abundant bacterium was performed. Our results suggest various microbial communities significantly changed with direct relation to critical diseases, such as Type 2 Diabetes, Obesity, Type 1 Diabetes and atherosclerosis. The findings are strongly assertive for each other as both nares and gut data were matching and agreeing with the literature, paving the road for potential probiotic therapeutics for T2D.","PeriodicalId":249153,"journal":{"name":"2021 3rd Novel Intelligent and Leading Emerging Sciences Conference (NILES)","volume":"32 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Potential probiotics for viral triggered type 2 diabetes\",\"authors\":\"Mariam Oweda, Joseph N. Tanyous, M. Hamed, M. El-Hadidi\",\"doi\":\"10.1109/NILES53778.2021.9600499\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The scientific literature is full of studies that provide evidence highlighting the role of microbiome in type 2 diabetes (T2D) development and progression, still, discrepancies are evident when studying the link between certain taxonomic groupings and T2D, thus, eliminating the discrepancy between such studies is crucial to build on a robust systematic approach to identify the possible linkage between such taxonomic groups and diabetes development and progression, hence developing a potential treatment. Here we aimed to use a publicly available data set of gut and nares microbiome of prediabetic individuals subjected to viral infections and controls of prediabetic healthy individuals. Analysis was done for taxa differential abundance followed by Taxon set enrichment analysis (TSEA), then, Correlations between each of the differentially abundant bacterium was performed. Our results suggest various microbial communities significantly changed with direct relation to critical diseases, such as Type 2 Diabetes, Obesity, Type 1 Diabetes and atherosclerosis. The findings are strongly assertive for each other as both nares and gut data were matching and agreeing with the literature, paving the road for potential probiotic therapeutics for T2D.\",\"PeriodicalId\":249153,\"journal\":{\"name\":\"2021 3rd Novel Intelligent and Leading Emerging Sciences Conference (NILES)\",\"volume\":\"32 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"2021 3rd Novel Intelligent and Leading Emerging Sciences Conference (NILES)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1109/NILES53778.2021.9600499\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"2021 3rd Novel Intelligent and Leading Emerging Sciences Conference (NILES)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/NILES53778.2021.9600499","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
科学文献中大量的研究都强调了微生物组在2型糖尿病(T2D)发展和进展中的作用,然而,在研究某些分类类群与T2D之间的联系时,差异是明显的,因此,消除这些研究之间的差异对于建立一个强大的系统方法来确定这些分类类群与糖尿病发展和进展之间可能的联系至关重要。因此开发了一种潜在的治疗方法。在这里,我们的目的是使用公开可用的数据集,包括遭受病毒感染的糖尿病前期个体的肠道和鼻腔微生物组,以及糖尿病前期健康个体的对照组。首先进行分类群差异丰度分析,然后进行分类群富集分析(Taxon set enrichment Analysis, TSEA),然后进行差异丰度细菌之间的相关性分析。我们的研究结果表明,各种微生物群落发生了显著变化,与2型糖尿病、肥胖、1型糖尿病和动脉粥样硬化等关键疾病有直接关系。这一发现相互之间具有很强的说服力,因为鼻腔和肠道数据都与文献相匹配,并与文献一致,为潜在的T2D益生菌治疗铺平了道路。
Potential probiotics for viral triggered type 2 diabetes
The scientific literature is full of studies that provide evidence highlighting the role of microbiome in type 2 diabetes (T2D) development and progression, still, discrepancies are evident when studying the link between certain taxonomic groupings and T2D, thus, eliminating the discrepancy between such studies is crucial to build on a robust systematic approach to identify the possible linkage between such taxonomic groups and diabetes development and progression, hence developing a potential treatment. Here we aimed to use a publicly available data set of gut and nares microbiome of prediabetic individuals subjected to viral infections and controls of prediabetic healthy individuals. Analysis was done for taxa differential abundance followed by Taxon set enrichment analysis (TSEA), then, Correlations between each of the differentially abundant bacterium was performed. Our results suggest various microbial communities significantly changed with direct relation to critical diseases, such as Type 2 Diabetes, Obesity, Type 1 Diabetes and atherosclerosis. The findings are strongly assertive for each other as both nares and gut data were matching and agreeing with the literature, paving the road for potential probiotic therapeutics for T2D.